SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-015620
Filing Date
2018-06-14
Accepted
2018-06-14 16:20:35
Documents
2
Period of Report
2018-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K REATA-OXFORD TERM LOAN reta-8k_20180614.htm 8-K 37510
2 EX-10.1 reta-ex101_63.htm EX-10.1 636118
  Complete submission text file 0001564590-18-015620.txt   674862
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 18899397
SIC: 2834 Pharmaceutical Preparations